Uzu Takashi, Kida Yasuo, Yamauchi Atsushi, Kume Shinji, Isshiki Keiji, Araki Shin-Ichi, Koya Daisuke, Haneda Masakazu, Kashiwagi Atsunori, Maegawa Hiroshi, Kikkawa Ryuichi
Shiga University of Medical Science, Otsu, Shiga, Japan.
J Am Soc Hypertens. 2012 Mar-Apr;6(2):124-31. doi: 10.1016/j.jash.2011.11.001. Epub 2011 Dec 22.
There is little evidence regarding the target blood pressure level in patients with type 2 diabetes mellitus without overt proteinuria.
We followed 608 Japanese patients with type 2 diabetes without apparent cardiovascular disease and overt proteinuria who underwent cerebral magnetic resonance imaging for a mean of 7.5 years. The patients were categorized according to their mean systolic blood pressure during the follow-up period (strict: <130 mm Hg, moderate: ≥130 and <140 mm Hg, poor: ≥ 140 mm Hg). The risks for the primary composite outcome of death or end-stage renal disease were not different among the three groups. The renal risk of the doubling of serum creatinine for the poor group was significantly higher than those in other groups. In addition, among the patients without silent cerebral infarction (SCI), the renal risk was significantly lower in the strict group than in the moderate group. Further, in both the SCI and non-SCI groups, strict blood pressure control slowed the progression of albuminuria.
In nonproteinuric diabetic patients without SCI, strict blood pressure control was associated with improved renal outcomes. There may be different effects of intensive blood pressure control on the renoprotection of diabetic patients according to their complications.
关于无明显蛋白尿的2型糖尿病患者的目标血压水平,几乎没有证据。
我们对608例无明显心血管疾病和明显蛋白尿的日本2型糖尿病患者进行了平均7.5年的随访,这些患者接受了脑磁共振成像检查。根据随访期间的平均收缩压对患者进行分类(严格组:<130 mmHg,中度组:≥130且<140 mmHg,较差组:≥140 mmHg)。三组患者的死亡或终末期肾病主要复合结局风险无差异。较差组血清肌酐翻倍的肾脏风险显著高于其他组。此外,在无无症状性脑梗死(SCI)的患者中,严格组的肾脏风险显著低于中度组。此外,在SCI组和非SCI组中,严格的血压控制均减缓了蛋白尿的进展。
在无SCI的非蛋白尿性糖尿病患者中,严格的血压控制与改善肾脏结局相关。根据并发症情况,强化血压控制对糖尿病患者肾脏保护的作用可能不同。